Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-006136
Filing Date
2024-08-16
Accepted
2024-08-16 16:25:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4515
  Complete submission text file 0001950047-24-006136.txt   6034
Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Subject) CIK: 0001689375 (see all company filings)

EIN.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40969 | Film No.: 241217022
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address
Dowden Nathan J (Reporting) CIK: 0001873392 (see all company filings)

Type: 144